Chat with us
Research Assistance
Online
  • Please enter your first name.

Brazil Metagenomics Market Size & Outlook, 2024-2030

The metagenomics market in Brazil is expected to reach a projected revenue of US$ 191.5 million by 2030. A compound annual growth rate of 14.3% is expected of Brazil metagenomics market from 2024 to 2030.

  • Biotechnology
    • Genomics & Genetic Engineering
      • Metagenomics Market Outlook
Revenue, 2023 (US$M)
$75.1
Forecast, 2030 (US$M)
$191.5
CAGR, 2024 - 2030
14.3%
Report Coverage
Brazil
GVR research-powered AI

Ask Prism AI about the metagenomics market

Get cited answers from GVR research on market growth, segments, regulations and forecasts.

  • Source-linked answers
  • Market-specific context
  • Traceable figures
Explore Prism AI

Brazil metagenomics market highlights

  • The Brazil metagenomics market generated a revenue of USD 75.1 million in 2023 and is expected to reach USD 191.5 million by 2030.
  • The Brazil market is expected to grow at a CAGR of 14.3% from 2024 to 2030.
  • In terms of segment, kits & reagents was the largest revenue generating product in 2023.
  • Sequencing & Data Analytics Services is the most lucrative product segment registering the fastest growth during the forecast period.


Metagenomics market data book summary

Market revenue in 2023USD 75.1 million
Market revenue in 2030USD 191.5 million
Growth rate14.3% (CAGR from 2023 to 2030)
Largest segmentKits & reagents
Fastest growing segmentSequencing & Data Analytics Services
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationKits & Reagents, Sequencing & Data Analytics Services, Software
Key market players worldwideBio-Rad Laboratories Inc, Illumina Inc, PerkinElmer, Thermo Fisher Scientific Inc, Novogene, Promega, Qiagen NV, Takara Bio Inc, Oxford Nanopore Technologies PLC, Roche Holding AG


Other key industry trends

  • In terms of revenue, Brazil accounted for 3.7% of the global metagenomics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil metagenomics market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 191.5 million by 2030.

The Brazil metagenomics market is expected to continue R&D of molecular test kits using NGS to diagnose brain disorders such as autism through startup companies such as Mendelics and Genius. Furthermore, the presence of a naturally diverse ethnic demographic in the region is expected to boost R&D for NGS-derived diagnostic kits and therapies for certain rare diseases.

These potential avenues for further development of NGS applications are expected to fuel the market growth in this region during the forecast period. The improving infrastructure, expanding sequencing technologies, and increasing interest of global players in this country are also driving the market.

For instance, in November 2019, Veritas Intercontinental signed an agreement with genetic testing lab Genomika, based in Brazil, to offer whole-genome and exome sequencing services in this region.

No credit card required*

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study
Turnaround
5–10 working days

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Metagenomics Market Companies

NameProfile# EmployeesHQWebsite
Thermo Fisher Scientific IncView profile 122,000168 Third Avenue, Waltham, MA, United States, 02451www.thermofisher.com
Roche Holding AGView profile 103,605Grenzacherstrasse 124, Basel, Switzerland, 4070www.roche.com
Illumina IncView profile 9,3005200 Illumina Way, San Diego, CA, United States, 92122www.illumina.com
Bio-Rad Laboratories IncView profile 8,0301000 Alfred Nobel Drive, Hercules, CA, United States, 94547www.bio-rad.com
Qiagen NVView profile 5,900Hulsterweg 82, Venlo, LI, Netherlands, 5912 PLwww.qiagen.com
Takara Bio IncView profile 1,793Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, Japan, 520-0058www.takara-bio.co.jp
PerkinElmerView profile 10001+Waltham, Massachusetts, United States, North Americawww.perkinelmer.com
NovogeneView profile 501-1000Beijing, Beijing, China, Asiaen.novogene.com/
PromegaView profile 5001-10000Madison, Wisconsin, United States, North Americawww.promega.com/es
Oxford Nanopore Technologies PLCView profile 1,133Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, United Kingdom, OX4 4DQwww.nanoporetech.com

Brazil Metagenomics Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Metagenomics Market Outlook will help companies and investors design strategic landscapes.


Kits & Reagents was the largest segment with a revenue share of 61.52% in 2023.

Horizon Databook has segmented the Brazil metagenomics market based on kits & reagents, sequencing & data analytics services, software covering the revenue growth of each sub-segment from 2018 to 2030.




The Brazil metagenomics market is expected to continue R&D of molecular test kits using NGS to diagnose brain disorders such as autism through startup companies such as Mendelics and Genius. Furthermore, the presence of a naturally diverse ethnic demographic in the region is expected to boost R&D for NGS-derived diagnostic kits and therapies for certain rare diseases.

These potential avenues for further development of NGS applications are expected to fuel the market growth in this region during the forecast period. The improving infrastructure, expanding sequencing technologies, and increasing interest of global players in this country are also driving the market.

For instance, in November 2019, Veritas Intercontinental signed an agreement with genetic testing lab Genomika, based in Brazil, to offer whole-genome and exome sequencing services in this region.

  • Brazil Metagenomics Market Application Outlook (Revenue, USD Million , 2018-2030)
    • Others
    • Clinical Diagnostics
    • Drug Discovery
    • Biotechnology
    • Environmental
    • Food & nutrition
  • Brazil Metagenomics Market Technology Outlook (Revenue, USD Million , 2018-2030)
    • Whole Genome Sequencing
    • Shotgun Sequencing
    • Others
    • 16S Sequencing
  • Brazil Metagenomics Market Product Outlook (Revenue, USD Million , 2018-2030)
    • Sequencing & Data Analytics Services
    • Kits & Reagents
    • Software
  • Brazil Metagenomics Market Workflow Outlook (Revenue, USD Million , 2018-2030)
    • Pre-sequencing
    • Sequencing
    • Data Analysis

Reasons to subscribe to Metagenomics Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Metagenomics Market Outlook databook

  • Our clientele includes a mix of Metagenomics Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Brazil Metagenomics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Brazil Metagenomics Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Brazil Metagenomics Market, 2018-2030 (US$M)

No Access Stack Chart

Brazil metagenomics market statistics, by application, 2018-2030 (US$M)

No Access Pie Chart

Brazil metagenomics market statistics, by application, 2018-2030 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more